是这个么
回答: 辉瑞执行长布拉(AlbertBourla)9日在旧金山出席会议时指出: 由 Lv200 于 2023-01-10 12:02
PFIZER is not in talks with Chinese authorities to license a generic version of its Covid-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, chief executive Albert Bourla said on Monday. 6park.comReferring to that report, Bourla speaking at JPMorgan’s healthcare conference in San Francisco, said “We are not in discussions. We have an agreement already for local manufacturing of Paxlovid in China. So we have a local partner that will make Paxlovid for us, and then we will sell it to the Chinese market.”
|